Analyzing the evolution and bacterial clearance of Clostridioides difficile infections
Clostridioides Difficile Infection: Prospective Cohort Analyzing CLInic Evolution and Bacterial Clearance
This study looks at how Clostridioides difficile infections change over time and how well different treatments work for French-speaking adults in the hospital.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fondation Hôpital Saint-Joseph Academic / other |
| Locations | 1 site (Paris) |
| Trial ID | NCT06030245 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients hospitalized with microbiologically documented Clostridioides difficile infections or recurrences. It aims to analyze the clinical evolution of the infection and the effectiveness of bacterial clearance methods. The study will involve French-speaking patients over 18 years of age who consent to participate. Data will be collected from patients treated at the Fondation Hôpital Saint-Joseph in Paris.
Who should consider this trial
Good fit: Ideal candidates are French-speaking adults over 18 years old with documented Clostridioides difficile infections.
Not a fit: Patients under guardianship, those deprived of liberty, or pregnant/breastfeeding individuals may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of Clostridioides difficile infections and improve treatment strategies.
How similar studies have performed: While there have been studies on Clostridioides difficile, this specific observational approach to analyze clinical evolution and bacterial clearance is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 18 years of age * Patients hospitalized in a department of GH Paris Saint-Joseph with a microbiologically documented Clostridioides difficile infection or a microbiologically documented Clostridioides difficile recurrence. * Patient to be treated for Clostridioides difficile infection * French-speaking patient * Patients who do not object to their participation in the study Exclusion Criteria: * Patients under guardianship or curatorship * Patient deprived of liberty * Patient under court protection * Pregnant or breast-feeding patient
Where this trial is running
Paris
- Fondation Hôpital Saint-Joseph — Paris, France (Recruiting)
Study contacts
- Principal investigator: Assaf MIZRAHI, MD — Fondation Hôpital Saint-Joseph
- Study coordinator: Assaf MIZRAHI, MD
- Email: amizrahi@ghpsj.fr
- Phone: 144127030
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.